CD133 does not enrich for the stem cell activity in vivo in adult mouse prostates
Authors:
Open Access
- 1 May 2016
- journal article
- Published by Elsevier in Stem Cell Research
- Vol. 16 (3) , 597-606
Abstract
No abstract availableKeywords
Funding Information
- NIH (P30 AI036211, P30 CA125123, S10 RR024574, R01 DK092202, P30 CA125123)
- NIH
- NIH
This publication has 35 references indexed in Scilit:
- Loss of oncogenic Notch1 with resistance to a PI3K inhibitor in T-cell leukaemiaNature, 2014
- Tumor endothelial marker 1–specific DNA vaccination targets tumor vasculatureJournal of Clinical Investigation, 2014
- The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populationsProceedings of the National Academy of Sciences, 2009
- The Stem Cell Marker CD133 (Prominin-1) Is Expressed in Various Human Glandular EpitheliaJournal of Histochemistry & Cytochemistry, 2008
- TGF-β inhibits Akt-induced transformation in intestinal epithelial cellsSurgery, 2006
- Prospective Identification of Tumorigenic Prostate Cancer Stem CellsCancer Research, 2005
- Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancerCell and tissue research, 2004
- Isolation and culture of human muscle-derived stem cells able to differentiate into myogenic and neurogenic cell lineagesThe Lancet, 2004
- Human skin‐derived stem cells migrate throughout forebrain and differentiate into astrocytes after injection into adult mouse brainJournal of Neuroscience Research, 2004
- WNT-1 Signaling Inhibits Apoptosis by Activating β-Catenin/T Cell Factor–Mediated TranscriptionJournal of Cell Biology, 2001